Louis DeGennaro - President and CEO, Leukemia & Lymphoma Society
Stephanie Devaney - Project Manager, Precision Medicine Initiative, White House Office of Chief of Staff
Brian Druker - Director, Oregon Health and Science University Knight Cancer Institute; JELD-WEN Chair of Leukemia Research; Investigator, Howard Hughes Medical Institute
Mary Dwight - Senior Vice President, Policy and Community Affairs, Cystic Fibrosis Foundation
Andrea Ferris - President and Chairman, LUNGevity Foundation
Leah McCormick Howard - Vice President, Government Relations & Advocacy, National Psoriasis Foundation
Clifford Hudis - Vice President for Government Relations and Chief Advocacy Officer; Chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center
Kathy Hudson - Deputy Director for Science, Outreach, and Policy, National Institutes of Health
C. Jimmy Lin - Founder & President, Rare Genomics Institute
Peter Margolis - Professor of Pediatrics and Director of Research, James M. Anderson Center for Health System Excellence, Cincinnati Children's Hospital Medical Center
Bray Patrick-Lake - Director, Stakeholder Engagement, Clinical Trials Transformation Initiative, Duke University; Co-Chair, NIH Advisory Committee to the Director Working Group, Precision Medicine Initiative; Senior Fellow, FasterCures
Jessica Polka - Postdoctoral Research Fellow, Silver Lab, Department of Systems Biology, Harvard Medical School
Jeffrey Shuren - Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Josh Sommer - Executive Director, Chordoma Foundation
Murray Stewart - Chief Medical Officer, Pharmaceuticals, GSK
Rudolph Tanzi - Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Vice Chair, Neurology Research, Massachusetts General Hospital
Gillian Tett - U.S. Managing Editor and Columnist, Financial Times
Jon White - Deputy National Coordinator, Office of the National Coordinator for Health Information Technology, U.S. Department of Health and Human Services
Jedd Wolchok - Chief, Melanoma and Immunotherapeutics Service, and Lloyd J. Old and Virginia and Daniel K. Ludwig Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center
Keith Yamamoto - Vice Chancellor for Research; Executive Vice Dean, School of Medicine; Professor, Cellular & Molecular Pharmacology, University of California, San Francisco